A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead Lines
Clinical trial NCT05152576 · COMPLETED
Trial details
- NCT number
- NCT05152576
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-29
- Primary completion
- 2022-09-06
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.